Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

GlaxoSmithKline plc : Director/PDMR Shareholding

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 08:11pm CEST

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
05/27 GLAXOSMITHKLINE PHARMACEUTICALS : `s New CEO Is Off to a Good Start
05/27 GLAXOSMITHKLINE : 15.9% Potential Upside Indicated by Berenberg
05/25 GLAXOSMITHKLINE : New Malaria Study Findings Reported from GlaxoSmithKline plc (..
05/25 GLAXOSMITHKLINE : Data on Pharmaceutical Science Described by Researchers at Gla..
05/25 GLAXOSMITHKLINE : Study Data from GlaxoSmithKline plc Provide New Insights into ..
05/25 GLAXOSMITHKLINE : New Vaccines Findings Reported from GlaxoSmithKline plc (Struc..
05/25 GLAXOSMITHKLINE : Recent Research from GlaxoSmithKline plc Highlight Findings in..
05/25 GLAXOSMITHKLINE : Recent Research from GlaxoSmithKline plc Highlight Findings in..
05/23 UK competition watchdog accuses Merck of obstructing biosimilars
05/22 GLAXOSMITHKLINE : Hikma sales blow
More news
Sector news : Pharmaceuticals - NEC
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/25 FDA drug approvals rebound from last year, up over 100% yoy
05/25 FDA chief says agency needs to play a role in constraining drug prices by eas..
05/22 'Safer' Dividend Healthcare Dog's 55% Top Gain Equals Sum Of Four Tailing It ..
05/22 Healthcare Dogs See Psychemedics Tops By Gains In May
05/22 Tracking Tweedy Browne Portfolio - Q1 2017 Update
Advertisement
Financials ( GBP)
Sales 2017 30 028 M
EBIT 2017 8 332 M
Net income 2017 4 381 M
Debt 2017 13 977 M
Yield 2017 4,87%
P/E ratio 2017 19,22
P/E ratio 2018 16,67
EV / Sales 2017 3,16x
EV / Sales 2018 3,03x
Capitalization 80 818 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 17,7  GBP
Spread / Average Target 8,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Emma Walmsley Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Patrick J. T. Vallance Executive Director, President-R&D
Roy Malcolm Anderson Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC5.22%103 436
JOHNSON & JOHNSON10.69%341 901
ROCHE HOLDING LTD.14.62%236 581
NOVARTIS AG6.07%211 457
PFIZER INC.-1.05%191 398
MERCK & CO., INC.10.28%177 567
More Results